Osmotic pressure measurement device and measurement method.
Italy T02006A000508. 2006.
Dispositivo perfezionato di misura della pressione osmotica e relative procedimento di misura.
Italy TO2007A000177. 2007.
Osmotic pressure beyond concentration restrictions.
J Phys Chem B.
2007 Oct 11;111(40):11770-5. doi: 10.1021/jp075834j. Epub 2007 Sep 19. PubMed PMID:
17880133.
Fast membrane osmometer as alternative to freezing point and vapor pressure osmometry.
Anal Chem.
2008 Apr 1;80(7):2617-22. doi: 10.1021/ac7023987. Epub 2008 Mar 4. PubMed PMID:
18315010.
Comment on "Osmotic pressure beyond concentration restrictions".
J Phys Chem B.
2008 Dec 11;112(49):15941-2; discussion 15943. doi: 10.1021/jp8031995. PubMed PMID:
19367952.
Quality Control Method and Micro/Nano-channeled Devices.
USA patent application PCT/US2009/041957. 2009.
Analysis of a nanochanneled membrane structure through convective gas flow.
Journal of Micromechanics and Microengineering. 2009; 19(11):115018-115029. doi: 10.1088/0960-1317/19/11/115018.
Electrokinetic Transport of Molecules Through Nanochanneled Membranes.
Proceedings of the ... ASME Design Engineering Technical Conferences. ASME Design Engineering Technical Conferences. 2010; 43925:131-134. doi: 10.1115/NEMB2010-13236.
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
Trends Pharmacol Sci.
2010 May;31(5):199-205. doi: 10.1016/j.tips.2010.01.003. Epub 2010 Feb 19. Review. PubMed PMID:
20172613; PubMed Central PMCID:
PMC2862836.
Nanochannel systems for personalized therapy and laboratory diagnostics.
Curr Pharm Biotechnol.
2010 Jun;11(4):343-65. doi: 10.2174/138920110791233280. Review. PubMed PMID:
20199382.
Enabling individualized therapy through nanotechnology.
Pharmacol Res.
2010 Aug;62(2):57-89. doi: 10.1016/j.phrs.2009.12.011. Epub 2010 Jan 5. Review. PubMed PMID:
20045055; PubMed Central PMCID:
PMC2886806.
Confinement effects on monosaccharide transport in nanochannels.
J Phys Chem B.
2010 Sep 2;114(34):11117-26. doi: 10.1021/jp103519d. PubMed PMID:
20738139.
A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery.
Lab Chip.
2010 Nov 21;10(22):3074-83. doi: 10.1039/c0lc00013b. Epub 2010 Aug 10. PubMed PMID:
20697650.
Acute and Chronic Pain: Where we are and where we have to go Nanomedicine: ushering in a new era of pain management.
European Journal of Pain Supplements. 2011; 5(2):317-322.
NanoGlands: NanoFluidic Implants for Personalized Medicine.
ASME Mechanical Engineering. 2011; 133(2):23-26.
Hierarchical modeling of diffusive transport through nanochannels by coupling molecular dynamics with finite element method.
Journal of Computational Physics. 2011; 230:5722-5731.
Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration.
Pharm Res.
2011 Feb;28(2):292-300. doi: 10.1007/s11095-010-0195-6. Epub 2010 Jul 1. PubMed PMID:
20593302.
Device for rapid and agile measurement of diffusivity in micro- and nanochannels.
Anal Chem.
2011 Apr 15;83(8):3096-103. doi: 10.1021/ac1033648. Epub 2011 Mar 24. PubMed PMID:
21434670.
A low-voltage electrokinetic nanochannel drug delivery system.
Lab Chip.
2011 Aug 7;11(15):2526-34. doi: 10.1039/c1lc00001b. Epub 2011 Jun 15. PubMed PMID:
21677944.
Gated and near-surface diffusion of charged fullerenes in nanochannels.
ACS Nano.
2011 Dec 27;5(12):9382-91. doi: 10.1021/nn2037863. Epub 2011 Nov 14. PubMed PMID:
22032773.
Nanotechnologies and regenerative medical approaches for space and terrestrial medicine.
Aviat Space Environ Med.
2012 Nov;83(11):1025-36. doi: 10.3357/asem.3307.2012. Review. PubMed PMID:
23156089.
Nanochanneled Device and Related Methods.
USA patent application 13/264,069. 2013.
Scaling and crossovers in molecular transport in nano-fluidic systems.
Applied physics letters. 2013; 103(11):113104-113108. doi: 10.1063/1.4819156.
Nanochanneled device and related methods.
USA 8,480,637. 2013.
Sustained Drug Delivery From Solid Implants with Nanochannel Membranes.
USA patent application PCT/US2013/022987. 2013.
Device and Method for Sustained Release of Therapeutic Agent.
USA patent application 13/659,064. 2013.
Nanochanneled Device and Related Methods.
USA patent application 13/698,926. 2013.
Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health.
Anal Bioanal Chem.
2013 Feb;405(5):1547-57. doi: 10.1007/s00216-012-6484-7. Epub 2012 Oct 23. PubMed PMID:
23090650.
Silicon micro- and nanofabrication for medicine.
Adv Healthc Mater.
2013 May;2(5):632-66. doi: 10.1002/adhm.201200214. Epub 2013 Apr 15. Review. PubMed PMID:
23584841; PubMed Central PMCID:
PMC3777663.
Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulations.
Curr Drug Targets.
2013 Aug;14(9):1061-9. doi: 10.2174/13894501113149990165. PubMed PMID:
23721184.
Differential scanning calorimetry as a tool to investigate the transfer of anticancer drugs to biomembrane model.
Curr Drug Targets.
2013 Aug;14(9):1053-60. doi: 10.2174/1389450111314090013. PubMed PMID:
23651164.
Characterization of a nanogland for the autotransplantation of human pancreatic islets.
Lab Chip.
2013 Sep 21;13(18):3675-88. doi: 10.1039/c3lc50601k. PubMed PMID:
23884326.
Leveraging nanochannels for universal, zero-order drug delivery in vivo.
J Control Release.
2013 Dec 28;172(3):1011-9. doi: 10.1016/j.jconrel.2013.09.028. Epub 2013 Oct 3. PubMed PMID:
24095805.
Functional validation of an implantable medical dosing device by MRI at 3T.
Annu Int Conf IEEE Eng Med Biol Soc.
2014;2014:2346-7. doi: 10.1109/EMBC.2014.6944091. PubMed PMID:
25570459.
Nanotechnology-based Implant for Long Term Testosterone Replacement.
The Journal of urology. 2014; 191(4):e485–e486. doi: 10.1016/j.juro.2014.02.1177.
Robotic UV-Vis apparatus for long-term characterization of drug release from nanochannels.
Measurement Science and Technology. 2014; 25(2):027003. doi: 10.1088/0957-0233/25/2/027003.
Sustained zero-order release of intact ultra-stable drug-loaded liposomes from an implantable nanochannel delivery system.
Adv Healthc Mater.
2014 Feb;3(2):230-8. doi: 10.1002/adhm.201300188. Epub 2013 Jul 23. PubMed PMID:
23881575; PubMed Central PMCID:
PMC3970317.
Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System.
Curr Drug Targets.
2015;16(14):1645-9. doi: 10.2174/138945011614151119125541. PubMed PMID:
25706254.
Nanochanneled Device with Electrodes and Related Methods.
USA patent application 61/861,070. 2015.
Impedance characterization, degradation, and in vitro biocompatibility for platinum electrodes on BioMEMS.
Biomed Microdevices.
2015 Feb;17(1):24. doi: 10.1007/s10544-014-9909-6. PubMed PMID:
25663443; PubMed Central PMCID:
PMC4489853.
Delivering enhanced testosterone replacement therapy through nanochannels.
Adv Healthc Mater.
2015 Feb 18;4(3):446-51. doi: 10.1002/adhm.201400348. Epub 2014 Oct 1. PubMed PMID:
25274059.
Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane.
Nanoscale.
2015 Mar 12;7(12):5240-8. doi: 10.1039/c4nr06209d. PubMed PMID:
25707848; PubMed Central PMCID:
PMC4386861.
The nanochannel delivery system for constant testosterone replacement therapy.
J Sex Med.
2015 Jun;12(6):1375-80. doi: 10.1111/jsm.12897. Epub 2015 Apr 30. PubMed PMID:
25930087.
Sustained Administration of Hormones Exploiting Nanoconfined Diffusion through Nanochannel Membranes.
Materials (Basel).
2015 Aug;8(8):5276-5288. doi: 10.3390/ma8085241. Epub 2015 Aug 13. PubMed PMID:
27293533; PubMed Central PMCID:
PMC4898476.
Sustained Delivery of Tamoxifen from a Nanofluidic Delivery Platform.
Drug delivery letters. 2016; 6(2):127-133. doi: 10.2174/2210303106666161129163850.
3D printed encapsulation system for human mesenchymal stem cells differentiated into islet-like insulin producing aggregates for diabetes treatment.
J Tissue Eng.. 2016; 7:2041731416638198. doi: 10.1177/2041731416638198.
The Emerging Role of Nanotechnology in Cell and Organ Transplantation.
Transplantation.
2016 Aug;100(8):1629-38. doi: 10.1097/TP.0000000000001100. Review. PubMed PMID:
27257995; PubMed Central PMCID:
PMC4961523.
Nanochannel Implants for Minimally-Invasive Insertion and Intratumoral Delivery.
J Biomed Nanotechnol.
2016 Oct;12(10):1907-15. doi: 10.1166/jbn.2016.2288. PubMed PMID:
29360309.
Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.
Int J Obes (Lond).
2016 Nov;40(11):1776-1783. doi: 10.1038/ijo.2016.129. Epub 2016 Jul 27. PubMed PMID:
27460601.
The active modulation of drug release by an ionic field effect transistor for an ultra-low power implantable nanofluidic system.
Nanoscale.
2016 Nov 10;8(44):18718-18725. doi: 10.1039/c6nr06235k. PubMed PMID:
27787528; PubMed Central PMCID:
PMC5166607.
What would you like to do?